Results 91 to 100 of about 680,934 (308)

SARS-CoV-2 Virology

Infectious Disease Clinics of North America, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire   +3 more sources

Organizing the interface—Plasma membrane architecture and receptor dynamics in virus‐cell interactions

FEBS Letters, EarlyView.
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley   +1 more source

T Cell responses to whole SARS Coronavirus in humans [PDF]

, 2008
Effective vaccines should confer long-term protection against future outbreaks of severe acute respiratory syndrome (SARS) caused by a novel zoonotic coronavirus (SARS-CoV) with unknown animal reservoirs.
Douek, Daniel C., McMichael, A., Temperton, Nigel J., Lin, C.L., Tran, Bac-Hai, Brenchley, JM, Screaton, Gavin R., Yan, Huiping, Yan, H., Tran, BH, Douek, DC, Ma, Shiwu, Temperton, N., Li, Chris Ka-fai, Wu, H., Wu, Hao, Hou, Jin-lin, Yan, H, Xu, XN, Ma, S., Tran, H., Screaton, GR, Mongkolsapaya, J., Mongkolsapaya, Juthathip, McMichael, Andrew J., Ma, S, Tang, X., Weiss, R., Xu, X., Hou, JL, Wang, L., Li, C., Tang, X, Zhang, Mingxia, Weiss, RA, Wang, L, Lin, Chen-lung Steve, Weiss, Robin A., Screaton, G., Mcmichael, AJ, Lin, CL, Hou, J., Wu, H, Mcmichael, Andrew, Xu, Xiao-Ning, Brenchley, J., Brenchley, Jason M., Mongkolsapaya, J, Wang, Lili, Douek, D., Tang, Xiaoping, Li, CK, Zhang, M, Temperton, NJ, Zhang, M.   +54 more
core   +1 more source

Expression of SARS-CoV-2 proteins from rVSV_NJ-SARS-CoV-2. [PDF]

, 2021
To check the expression of SARS-CoV-2 RBD, S1, and SF from rVSVNJ-SARS-CoV-2 infected cells, BHK-21 cells were infected with the virus at an MOI of 6. After six hours incubation at 37°C, cell lysates were prepared and protein expression was determined by
Taewoo Kim (1456888), Ryan M. Troyer (11846435), Sun-Je Woo (10336425), Eric J. Arts (11846438), Kunyu Wu (11846408), S. M. Mansour Haeryfar (8069414), Jung-ah Choi (6520727), Seungho Choo (11846423), Gregory A. Dekaban (9694262), Brock Fenton (359975), Gyoung Nyoun Kim (11846405), Gippeum Lim (7253675), Na Hyung Kim (1315179), Nasrin Saeedian (11846411), Kate Parham (11846429), Jae-Hyung Chang (327325), Andrew Winterborn (11846426), Hoe Won Jeong (11846420), Eunsil Choi (8271039), Justin M. Donovan (11846432), Su-Kyeong Eo (11846417), Jimmy D. Dikeakos (8871386), Manki Song (317984), Yue Li (102191), Hayan Park (9182877), Eunji Yang (9182871), Seong-Gyu Kim (11846414), C. Yong Kang (11846444), Sangkyun Lee (312151), Sang Hwan Seo (10838327), Stephen D. Barr (11846441)   +30 more
core   +1 more source

SARS CoV- 2 vaccination induces antibodies against cardiolipin

BMC Research Notes, 2022
Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias, Anna Pafiti, Elie Deeba, Christina Christodoulou, Marios Pantzaris, Anastasia Lambrianides   +5 more
doaj   +1 more source

Profile of SARS-CoV-2 [PDF]

Wiener klinische Wochenschrift, 2020
SummaryThe recent emergence of a new coronavirus (severe acute respiratory syndrome coronavirus‑2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy.
Heinz, Franz X., Stiasny, Karin
openaire   +2 more sources

Biophysical approaches for studying viral entry

FEBS Letters, EarlyView.
Viruses infect all living organisms and have been responsible for major epidemics and pandemics. Their ongoing evolutionary battle with host defenses creates a constant need for improved tools to study viral behavior. Advancing methods to probe viral attachment, fusion, and genome release deepen our understanding of how infections begin and support the
Inbar Yosibash, Raya Sorkin
wiley   +1 more source

SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets [PDF]

, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the worldwide COVID-19 pandemic. Animal models are extremely helpful for testing vaccines and therapeutics and for dissecting the viral and host factors that ...
John M. Dye, Samantha E. Zak, Philip A. Bowling, Keersten M. Ricks, Shannon S. Hentschel, Eric D. Lee, Xiankun Zeng, April M. Babka, Korey L. Delp, Tamara L. Clements, Sara I. Ruiz, Elizabeth E. Zumbrun, Russel R. Bakken, Holly A. Bloomfield, Andrew S. Herbert, Jeffrey W. Koehler   +15 more
core   +1 more source

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

MedComm, 2021
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, Xiawei Wei   +4 more
doaj   +1 more source

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics [PDF]

The Lancet Infectious Diseases, 2021
Standl, Fabian, Jöckel, Karl-Heinz, Brune, Bastian, Schmidt, Börge, Stang, Andreas   +4 more
openaire   +2 more sources